证券代码：301035 证券简称：润丰股份 公告编号：2024-060 山东潍坊润丰化工股份有限公司 关于回购公司股份方案暨取得金融机构股票回购专 项贷款的公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示 山东潍坊润丰化工股份有限公司（以下简称"公司"）拟使用自有资金及股 票回购专项贷款资金以集中竞价交易方式回购公司部分人民币普通股 A 股股份。 1、回购资金总额：拟使用不低于人民币 6,500.00 万元（含本数）且不超过 人民币 13,000.00 万元（含本数）自有资金及股票回购专项贷款资金。 2、回购价格：不高于公司董事会审议通过回购股份决议前三十个交易日公 司股票交易均价的 150%，回购价格上限为 60.00 元/股。 3、回购数量：假设按照回购资金总额上限 13,000.00 万元、回购价格上限 60.00 元/股进行测算，预计回购股份数量为 216.67 万股，约占公司当前总股本 的 0.78%；按照回购资金总额下限 6,500.00 万元、回购价格上限 60.00 元/股测算， 预计回购股份数量为 108.33 万股，约占公司 ...

Investment Rating - The investment rating for the company is "Buy" with a target price indicating a potential return of over 20% within the next six months [5][12]. Core Insights - The company reported a total revenue of 9.785 billion yuan for the first three quarters of 2024, representing a year-on-year growth of 14.86%. However, the net profit attributable to shareholders decreased by 52.67% to 342 million yuan [1][2]. - The third quarter saw a significant revenue increase of 18.07% year-on-year, reaching 4.103 billion yuan, with a remarkable sequential growth of 37.30% [1][2]. - The decline in net profit is attributed to foreign exchange losses and increased sales expenses, with total expenses rising by approximately 63.5 million yuan compared to the previous year [3]. Revenue Breakdown - For the first three quarters, the revenue from herbicides, insecticides, and fungicides was 7.191 billion yuan, 1.547 billion yuan, and 944 million yuan, respectively, with herbicides showing a year-on-year increase of 9.41% [2]. - The company's revenue growth is primarily driven by the herbicide segment and the rapid advancement of the C model, which increased its share from 33% to 38% year-on-year [2]. Financial Performance - The gross margin for the first three quarters was 20.4%, a decrease of 2.3 percentage points from the previous year, mainly due to intense competition in the TO B business and high inventory costs in South America affecting the TO C business [2]. - The company expects a solid growth foundation for 2025 as high inventory levels in South America are gradually resolved, and it continues to enhance its TO C business, particularly in North America and the European Union [3]. Profit Forecast and Valuation - The forecasted net profit attributable to shareholders for 2024, 2025, and 2026 is 530 million yuan, 806 million yuan, and 1.038 billion yuan, respectively, reflecting a significant decline from previous years [3][4]. - The company’s earnings per share (EPS) for 2024 is projected to be 1.91 yuan, with a price-to-earnings (P/E) ratio of 24.50 [4][8].

Investment Rating - The report maintains a **Buy** rating for the company with a target price of **58.74 CNY** [2][4] Core Views - The company's operating data improved better than market expectations, with Q3 2024 revenue reaching **4.103 billion CNY**, a year-on-year increase of **18.07%**, and net profit attributable to shareholders of **160 million CNY**, a year-on-year decrease of **46.25%** [1] - Despite industry challenges and high raw material costs, the company's Q3 2024 revenue showed steady growth, with gross margin remaining above **20%** and slightly increasing quarter-on-quarter [1] - The company's business structure is optimizing, with the 2C model and higher-margin insecticide and fungicide products contributing to improved gross margins [1] - The company is expected to release growth momentum through continued investment in 2C business and expansion into high-barrier markets like the EU and North America [1] Financial Performance - Revenue for the first three quarters of 2024 reached **9.785 billion CNY**, a year-on-year increase of **14.86%**, while net profit attributable to shareholders was **342 million CNY**, a year-on-year decrease of **52.67%** [1] - The company's 2C revenue ratio increased from **32.88%** in the first three quarters of 2023 to **37.73%** in the same period of 2024, with a 2C gross margin of **29.37%**, significantly higher than the 2B gross margin of **14.91%** [1] - The revenue share of insecticides and fungicides reached **25.46%** in the first three quarters of 2024, with a gross margin approximately **6%** higher than herbicides [1] Future Outlook - The company's EPS for 2024-2026 is adjusted to **1.78**, **3.63**, and **4.58 CNY**, respectively, due to industry uncertainties and exchange rate fluctuations [2] - The company's gross margin is expected to improve further as high-cost inventory is gradually digested, and the 2C business model matures, leading to higher net profit margins [1] - Expansion into the EU and North American markets is expected to reduce reliance on the Latin American market, improving the company's financial statements [1] Financial Ratios and Projections - The company's revenue is projected to grow from **12.391 billion CNY** in 2024 to **16.401 billion CNY** in 2026, with net profit attributable to shareholders increasing from **496 million CNY** in 2024 to **1.277 billion CNY** in 2026 [3] - Gross margin is expected to remain stable, ranging from **20.7%** in 2024 to **21.6%** in 2026, while net margin is projected to improve from **4.0%** in 2024 to **7.8%** in 2026 [3] - ROE is forecasted to increase from **7.5%** in 2024 to **15.8%** in 2026, reflecting improved profitability and operational efficiency [3]

2、培训地点：润丰股份会议室 3、培训人员：刘俊杰 4、培训对象：润丰股份实际控制人、董事、监事、高级管理人员及部分中 层以上管理人员 5、培训方式：现场、视频授课 一、培训基本情况 1、培训时间：2024年10月24日 东北证券股份有限公司 关于山东潍坊润丰化工股份有限公司 2024年度持续督导培训报告 东北证券股份有限公司（以下简称"东北证券"或"保荐机构"）作为山东 潍坊润丰化工股份有限公司（以下简称"润丰股份"或"公司"）首次公开发行 股票并在创业板上市持续督导保荐机构，根据《证券发行上市保荐业务管理办法》、 《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等有关规定， 于 2024 年 10 月 24 日对润丰股份的实际控制人、董事、监事、高级管理人员及 部分中层以上管理人员进行了培训，现将培训情况报告如下： 1 的了解和认识，有利于进一步提升润丰股份的规范运作水平，达到了预期的培训 效果。 （以下无正文） 2 （此页无正文，为《东北证券股份有限公司关于山东潍坊润丰化工股份有限公司 2024 年度持续督导培训报告》之签署页） 保荐代表人： 本次现场培训前，东北证券编制了培训讲义，并在现 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The report highlights that exchange losses have negatively impacted the company's performance, but there is optimism regarding the company's long-term growth potential [1][3] - The company aims to become a global leader in crop protection, with significant investments in IT and process improvements to enhance global operational capabilities [2] - The company is focusing on increasing its ToC (To Consumer) business share and expanding its product registration globally, particularly in high-barrier markets [2] Financial Performance Summary - For the first three quarters of 2024, the company achieved total revenue of 9.785 billion yuan, a year-on-year increase of 14.86% [1] - The net profit attributable to the parent company for the same period was 342 million yuan, a decrease of 52.67% year-on-year [1] - In Q3 2024, the company reported total revenue of 4.103 billion yuan, up 18.07% year-on-year and 37.30% quarter-on-quarter [1] - The net profit for Q3 2024 was 160 million yuan, down 46.25% year-on-year but up 451.86% quarter-on-quarter [1] Future Earnings Forecast - The company’s projected net profits for 2024, 2025, and 2026 are 542 million yuan, 807 million yuan, and 1.045 billion yuan respectively, with year-on-year growth rates of -29.7%, +48.9%, and +29.5% [3][5] - The expected P/E ratios for the same years are 25X, 17X, and 13X [3] Strategic Growth Initiatives - The company has outlined four main growth strategies in its new five-year plan: increasing the share of ToC business, expanding operations in North America and the EU, enhancing the share of insecticides and fungicides, and strengthening the development of the biopesticide segment [2]

Group 1: Export Status of Agricultural Chemical Products - Export quantity from January to September 2024 increased by 30.84% year-on-year, but the growth rate has decreased compared to the first half of 2024 (52.70%) [3] - Export value from January to June 2024 increased by 9.11% year-on-year, down from 13.01% in the first half of 2024 [3] - Average export price (USD/Kg) showed a decline from USD4.44/Kg in January 2023 to USD3.00/Kg in December 2023, with a recovery to USD3.10/Kg by September 2024 [3] - Significant drop in both export quantity and value in September 2024, with expectations of reduced growth in Q4 2024 compared to the first three quarters [3] Group 2: Company Performance in 2024 - Revenue for the first three quarters of 2024 increased by 14.86% year-on-year, with Q3 showing an 18.07% increase [4] - The proportion of TO C business revenue rose from 32.88% in 2023 to 37.73% in 2024, with expectations to reach approximately 40% for the full year [4] - TO C business gross margin is approximately 14 percentage points higher than TO B, reaching 29.37% [4] Group 3: Strategic Planning and Challenges - The company’s five-year strategic plan focuses on increasing TO C business share, expanding in North America and the EU, enhancing insecticide and fungicide business, and strengthening the biopesticide sector [4] - High inventory costs in subsidiaries, particularly in Brazil and Argentina, have negatively impacted gross margins [4] - Exchange rate fluctuations have led to a profit decrease of approximately 300 million yuan in the first three quarters of 2024 [4] Group 4: Sales and Marketing Expenses - Sales expenses increased by approximately 189.22 million yuan in the first three quarters, with significant rises in overseas employee salaries and travel expenses [5] - The company anticipates continued growth in sales expenses due to ongoing investments in TO C business development [5] - The sales expense ratio is expected to stabilize as revenue scales up, while management expense ratios are decreasing [5] Group 5: Market Risks and Future Outlook - The company faces collection risks in Latin America due to prolonged payment terms and declining farmer incomes [6] - Approximately 60% of the company’s business is in Latin America, which poses risks to financial metrics such as inventory turnover and debt ratios [6] - The company is cautious about growth in Latin America and is focusing on increasing its market share in North America and the EU to mitigate risks [6] Group 6: Incentive Plans and Communication - The company has launched a restricted stock incentive plan based on achieving a 30% growth target for 2025 and 45% for 2026, considering 2024 as a cyclical low [8] - The company has established a WeChat public account for timely and accurate communication with investors [8]

Investment Rating - The report maintains a "Buy" rating for the company [5][10]. Core Views - The company's Q3 performance shows strong recovery, with revenue nearing the levels seen in Q3 2022, indicating robust growth potential [2][3]. - The company is expected to enter a new development phase in 2025, driven by increased business in Europe and the US, which will provide greater revenue elasticity [3]. - The report forecasts EPS for 2024, 2025, and 2026 to be 2.17, 3.41, and 4.63 CNY respectively, with a target price set at 58.23 CNY [3][5]. Financial Summary - Revenue for 2022 was 14,460 million CNY, with a projected decline to 11,485 million CNY in 2023, followed by a slight increase to 11,733 million CNY in 2024 [1]. - Net profit attributable to the parent company was 1,413 million CNY in 2022, expected to drop to 771 million CNY in 2023, and further decline to 605 million CNY in 2024, before recovering to 950 million CNY in 2025 and 1,290 million CNY in 2026 [1]. - The company’s net profit margin is projected to improve from 4.47% in Q3 2023 to 9.0% in 2026 [3][9]. - The company’s total assets are expected to grow from 14,898 million CNY in 2023 to 20,596 million CNY by 2026 [9]. Performance Metrics - The company reported a Q3 revenue of 4,103 million CNY, a year-on-year increase of 18.07% and a quarter-on-quarter increase of 37.30% [3]. - The gross margin for Q3 was 20.56%, showing a slight increase from previous quarters [3]. - The company’s market capitalization is currently 13,228 million CNY, with a current share price of 47.47 CNY [6][10]. Strategic Initiatives - The company has launched a new equity incentive plan with net profit as the performance target for the years 2025-2027, reflecting a strategic focus on improving profitability [3]. - The agricultural chemical prices are showing signs of bottoming out, with expectations of price recovery in 2024 due to improved supply-demand dynamics [3].

证券代码：301035 证券简称：润丰股份 公告编号： 2024-052 山东潍坊润丰化工股份有限公司 第四届监事会第二十二次会议决议公告 本公司及监事会全体成员保证信息披露内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 山东潍坊润丰化工股份有限公司（以下简称"公司"）于 2024 年 10 月 25 日在公司会议室以现场与通讯表决相结合的方式召开了第四届监事会第二十二 次会议。会议通知已于 2024 年 10 月 18 日以书面通知的形式送达给全体监事。 会议应到监事 3 人，实到 3 人。会议由公司监事会主席孙建国先生召集和主持。 本次会议的召集和召开符合《中华人民共和国公司法》《深圳证券交易所上市公 司自律监管指引第 2 号——创业板上市公司规范运作》和《山东潍坊润丰化工股 份有限公司章程》的有关规定。 二、监事会会议审议情况 会议经全体监事讨论后形成如下决议： 1、审议通过《关于 2024 年第三季度报告的议案》 经审议，监事会认为：公司编制的《2024 年第三季度报告》符合法律、行 政法规、中国证监会和深圳证券交易所的规定，报告内容真实、准确、完整地反 映了公司 ...

证券简称：润丰股份 证券代码：301035 山东潍坊润丰化工股份有限公司 2024 年限制性股票激励计划（草案） 之 独立财务顾问报告 2024 年 10 月 | 一、释义 3 | | --- | | 二、声明 4 | | 三、基本假设 5 | | 四、本激励计划的主要内容 6 | | （一）激励对象的范围及分配情况 6 | | （二）激励方式、来源及数量 7 | | （三）限制性股票的有效期、授予日、归属安排 8 | | （四）限制性股票的授予价格及授予价格的确定方法 10 | | （五）激励计划的授予与归属条件 11 | | （六）激励计划其他内容 14 | | 五、独立财务顾问意见 15 | | （一）对润丰股份 年限制性股票激励计划是否符合政策法规规定的核查 2024 | | 意见 15 | | （二）对公司实行股权激励计划可行性的核查意见 16 | | （三）对激励对象范围和资格的核查意见 16 | | （四）对股权激励计划权益额度的核查意见 17 | | （五）对上市公司是否为激励对象提供任何形式的财务资助的核查意见 17 | | （六）对激励计划授予价格定价方式的核查意见 17 | | （七）股 ...

证券代码：301035 证券简称：润丰股份 公告编号：2024-054 一、公司 2021 年限制性股票激励计划已履行的相关审批程序 1、2021 年 10 月 14 日，公司召开第三届董事会第二十五次会议和第三届监 事会第十五次会议，审议通过了《关于公司<2021 年限制性股票激励计划（草案）> 及其摘要的议案》《关于公司<2021 年限制性股票激励计划实施考核管理办法> 的议案》等议案，公司独立董事就本次股权激励计划发表了独立意见，律师、独 立财务顾问出具了相应的报告。 2、2021 年 10 月 20 日，公司召开第三届董事会第二十六次会议和第三届监 事会第十六次会议，审议通过了《关于公司<2021 年限制性股票激励计划（草案 修订稿）>及其摘要的议案》《关于公司<2021 年限制性股票激励计划实施考核 管理办法（修订稿）>的议案》等议案，公司独立董事就本次股权激励计划发表 了独立意见，律师、独立财务顾问出具了相应的报告。 3、2021 年 10 月 15 日至 2021 年 10 月 24 日，公司对 2021 年限制性股票激 励计划首次授予部分激励对象名单与职务在公司内部进行了公示，在公示期内， 没 ...